Filter
973
Filtered Results: 973
Text search:
infant
prophylaxis
Featured
Recommendations
111
New Publications
345
Language
Document type
No document type
688
Guidelines
149
Studies & Reports
49
Manuals
40
Strategic & Response Plan
13
Training Material
11
Infographics
8
Situation Updates
7
Fact sheets
7
Online Courses
1
Countries / Regions
Kenya
56
India
53
Zambia
34
Tanzania
34
South Africa
33
Malawi
33
Nigeria
25
Ethiopia
25
Liberia
24
Nepal
24
Rwanda
24
Uganda
23
Namibia
23
Lesotho
19
Sierra Leone
17
Global
13
Zimbabwe
12
Ghana
11
Botswana
11
Asia
11
Africa
11
Cambodia
10
Bangladesh
10
Latin America and the Carribbean
10
Eswatini/ Swaziland
8
Western and Central Europe
8
Philippines
7
Myanmar / Burma
7
Cameroon
5
Pakistan
5
Mozambique
5
East and Southern Africa
4
South–East Asia Region
4
Burkina Faso
3
Haiti
3
Eastern Europe
3
Guinea
2
Senegal
2
South Sudan
2
Afghanistan
2
Syria
2
Indonesia
2
Papua New Guinea
2
Benin
2
North Macedonia
2
Yemen
2
Albania
2
Russia
2
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Gambia
1
Central African Republic
1
Brazil
1
Burundi
1
Ukraine
1
Bolivia
1
Libya
1
Madagascar
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Other region
1
Bhutan
1
Southern Africa
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
489
Clinical Guidelines
121
Women & Child Health
97
Public Health
24
Capacity Building
18
Key Resources
9
Pharmacy & Technologies
2
Toolboxes
HIV
242
TB
32
Caregiver
31
COVID-19
18
Pharmacy
18
AMR
13
Mental Health
12
Conflict
10
Ebola
9
Refugee
9
Rapid Response
7
NTDs
4
Zika
3
Specific Hazards
3
Disability
2
Natural Hazards
2
Global Health Education
2
Health Financing Toolbox
2
Cholera
1
Polio
1
NCDs
1
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Integrated management of childhood illness. The last update was in the IMCI chart booklet in 2014, but since then there have been significant updates on the management of sick young infant (SYI) aged up to 2 months. This 2019 update of the sick youn...
Integrated management of childhood illness. The last update was in the IMCI chart booklet in 2014, but since then there have been significant updates on the management of sick young infant (SYI) aged up to 2 months. This 2019 update of the sick youn...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Integrated management of childhood illness. The last update was in the IMCI chart booklet in 2014, but since then there have been significant updates on the management of sick young infant (SYI) aged up to 2 months. This 2019 update of the sick youn...
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Toolkit
HIV Treatment and Care
